Story
Insider Trading: Durable Capital Buys Goosehead Insurance, SRB Corp Sells $127.8M in Safety Insurance Group

Summary
Recent disclosures reveal significant insider trading, including a $9.1 million purchase of Goosehead Insurance by Durable Capital Partners and a $127.8 million sale of Safety Insurance Group stock by a major shareholder. Executives at Micron Technology and Charles Schwab also reported large stock sales.
A series of significant insider transactions were disclosed Tuesday, providing investors with a view into how key executives and major shareholders are positioning themselves. The activity was highlighted by a multi-million dollar purchase in Goosehead Insurance by a major investment firm and a substantial divestment in Safety Insurance Group by a 10% owner.
Major Insider Purchases
Corporate insiders reported several large stock acquisitions, often interpreted by market participants as a sign of confidence in their company's future prospects.
- Goosehead Insurance, Inc. (GSHD): Durable Capital Partners LP, a 10% owner, acquired 153,723 shares for approximately $9.1 million. The transactions occurred on July 24 and July 27, 2026, at prices between $57.75 and $62.00 per share.
- Albertsons Companies, Inc. (ACI): Executive Vice President Thomas M. Moriarty purchased 170,500 shares for a total of $1.96 million. The shares were bought on July 27, 2026, at a price of $11.509 each, as the stock traded near its 52-week low.
- Artiva Biotherapeutics, Inc. (ARTV): RA Capital Management, a director and 10% owner, bought 41,319 shares for $412,776 on July 24, 2026.
- MapLight Therapeutics, Inc. (MPLT): Director Troy Cox purchased 15,620 shares for $148,702 on July 28, 2026.
- Kearny Financial Corp. (KRNY): Director Curtland E. Fields acquired 14,700 shares for $138,273 on July 27, 2026.
Notable Insider Sales
On the sell side, several executives and large stakeholders divested significant portions of their holdings, with the largest transaction topping $127 million.
Ad- Safety Insurance Group Inc. (SAFT): SRB Corporation, a 10% owner, sold 1,240,352 shares for a total of approximately $127.8 million. The sale on July 27, 2026, occurred as the stock was trading near its 52-week high.
- Micron Technology Inc. (MU): President and CEO Sanjay Mehrotra sold shares totaling over $37.2 million in a series of transactions on July 24, 2026. The disclosures noted these sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted in January 2026.
- United Therapeutics Corp (UTHR): Chairperson and CEO Martine A. Rothblatt sold 9,500 shares for approximately $5 million on July 28, 2026. The sale followed the exercise of stock options.
- The Charles Schwab Corp (SCHW): Co-Chairman Charles R. Schwab sold 45,500 shares for a total of $4.6 million on July 24, 2026.
Context for Investors
Insider trading activity is closely monitored as it can offer clues into leadership's perspective on a company's valuation and outlook. While substantial purchases by executives or directors can be a bullish indicator, sales are not always a signal of negative sentiment.
Insider sales can be motivated by a variety of factors unrelated to a company's performance, including personal financial planning, tax obligations, or portfolio diversification. Transactions conducted under Rule 10b5-1 plans, as seen with Micron's CEO, are scheduled in advance to avoid conflicts of interest and may not reflect an executive's current view of the stock.
Read next
More on Stocks
CarMax Stock Surges on Strong Earnings Beat and Sales Rebound
CarMax reported fiscal second-quarter results that far exceeded analyst expectations, driven by a 13% jump in same-store sales and plans to resume its share buyback program.

Netflix Stock Gains After Deutsche Bank Upgrades to 'Buy'
Shares of the streaming giant rose after Deutsche Bank upgraded the stock to 'Buy' from 'Hold,' setting a $95 price target and citing a valuation opportunity following a prolonged selloff.

Amazon, GoodRx Prescription Subscriptions Gain Traction Amid Rising US Healthcare Costs
Amazon and GoodRx are seeing significant growth in their prescription drug subscription services as consumers seek alternatives to rising insurance premiums and out-of-pocket expenses.

SEC Proposes Scaling Back Sarbanes-Oxley Auditor Requirements
The U.S. Securities and Exchange Commission plans to reduce the number of companies required to have external auditors verify internal financial controls, a key post-Enron investor protection.